ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0175

Identifying Immuno-phenotypes in Juvenile Localized Scleroderma with RNA Sequencing

Christina Schutt1, Emily Mirizio2, Kaila Schollaert-Fitch2, Claudia Salgado3, Miguel Reyes-Mugica3 and Kathryn Torok2, 1University of Pittsburgh Medical Center, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, PA, 3University of Pittsburgh Medical Center, Pittsburgh

Meeting: ACR Convergence 2020

Keywords: Gene Expression, genomics, Pediatric rheumatology, Scleroderma, Scleroderma, Localized

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: Pediatric Rheumatology – Basic Science Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Juvenile localized scleroderma (jLS) is an autoimmune disease of the skin and underlying tissue characterized by an early inflammatory infiltrate followed by fibrosis and collagen deposition leading to atrophy.  Uncontrolled jLS results in significant disfigurement and functional disability.  Our goal was to determine the transcriptome within inflammatory and fibrotic LS tissue vs. healthy controls and identify potential molecular targets using RNA sequencing (RNAseq).  Differentially expressed genes (DEGs) identified in jLS patients were compared to histopathological features to determine correlation and were used to cluster LS patients according to common expression pathways.

Methods: RNAseq was performed on paraffin-embedded skin (n=28 jLS, n=10 pediatric healthy) using the Illumina HTS and TrueSeq Access library preparation.  Paired-end RNAseq data was aligned using STAR, corrected for batch effect and analyzed for DEGs using DESeq2.  Genes were analyzed using DEG cutoffs of log fold change > ±2.0, adjusted p< 0.05, and a false discovery rate (FDR) cutoff of < 0.05 for Reactome and enrichment software (GSEA©).  Standardized scoring was developed for inflammation and collagen deposition and was completed between 2 blinded pathologists.  Spearman’s correlation was used to determine significance between DEGs and histology scoring.

Results: We found 589 significant DEGs between jLS vs. pediatric healthy controls with the above cutoffs.  Hierarchical clustering using complete linkage of Euclidean distance demonstrated three distinct jLS groupings; Group 1, Group 2 and Healthy-Like (Figure 1).  In Group 1, 61 DEGs were identified which associate with interferon gamma signaling, MHC class II antigen presentation, and TCR signaling (p< 0.01).  Specifically, five are HLA class II genes, HLA-DQA1, HLA-DQB1, HLA-DRB5, HLA-DPA1, and HLA-DRB1 (p< 0.01, FC >2, FDR< 0.05).  Degree of inflammatory cell infiltrates significantly correlated with HLA-DPB1, HLA-DQA2, HLA-DRA, and STAT1 (rs > 0.5, p< 0.01).  Collagen thickness in upper reticular dermis had a positive correlation with HLA-DQA1 (rs=0.46, p=0.03).  In Group 2, 76 DEGs were identified, which associate with pathways of FGFR1 amplification, collagen formation and keratinization (p< 0.05).

Conclusion: The identified groupings of jLS patients showed two distinct genetic signatures, one with upregulated inflammatory-related pathways, which corresponded to inflammatory infiltrate score, and a second group with upregulated fibrosis-related pathways.  HLA Class II gene upregulation was observed within the inflammatory group, which has also been described for systemic sclerosis.  Interestingly also the immune-phenotype groups did not directly correspond with the patients clinical phenotype.  Further investigation into the relationship and functions of these genes in jLS tissue is underway.

Figure 1: Hierarchical Clustering using complete linkage of Euclidean Distance

Figure 2: Circos plot comparing clinical LS subtype to immune-phenotype clustering.


Disclosure: C. Schutt, None; E. Mirizio, None; K. Schollaert-Fitch, None; C. Salgado, None; M. Reyes-Mugica, None; K. Torok, None.

To cite this abstract in AMA style:

Schutt C, Mirizio E, Schollaert-Fitch K, Salgado C, Reyes-Mugica M, Torok K. Identifying Immuno-phenotypes in Juvenile Localized Scleroderma with RNA Sequencing [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/identifying-immuno-phenotypes-in-juvenile-localized-scleroderma-with-rna-sequencing/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identifying-immuno-phenotypes-in-juvenile-localized-scleroderma-with-rna-sequencing/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology